ArticleInvestigational new drugs2025

Safety and pharmacokinetics of FCN-437c, a novel cyclin-dependent kinase 4/6 inhibitor, in Chinese patients with hepatic impairment.

Jia Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.